Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized, Placebo-Controlled Phase II Trial of Aspirin for Vestibular Schwannomas

NCT03079999 is registered in ClinicalTrials.gov with Massachusetts Eye and Ear Infirmary as lead sponsor.

NCT NCT03079999
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03079999 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized, Placebo-Controlled Phase II Trial of Aspirin for Vestibular Schwannomas
Lead sponsor
Massachusetts Eye and Ear Infirmary
Phase
Phase 2
Overall status
Active, not recruiting
Start date
June 11, 2018
Completion date
February 28, 2029
Enrollment
97 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

acoustic neuroma, neurofibromatosis 2, vestibular schwannoma